SCHEMBL23913206

SCHEMBL23913206

c1ccc(-c2ccc3oc4cc(-c5nc(-c6cccc(-c7cccc8sc9ccccc9c78)c6)nc(-c6ccc7c(c6)oc6ccccc67)n5)ccc4c3c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.37
PLA2G4A P47712 3/20 0.37
PLA2G10 O15496 1/20 0.37
HCRTR1 O43613 1/20 0.35
PIM1 P11309 1/20 0.35
CSNK2A2 P19784 1/20 0.35
CSNK2B P67870 1/20 0.35
PIM3 Q86V86 1/20 0.35
PIM2 Q9P1W9 1/20 0.35
MMP12 P39900 2/20 0.34
MMP13 P45452 1/20 0.34
PRKDC P78527 2/20 0.34
LIMK1 P53667 2/20 0.34
ALOX5 P09917 1/20 0.33
CHEK2 O96017 1/20 0.33
CASP3 P42574 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
BRDT Q58F21 1/20 0.32
HSP90AA1 P07900 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23913404 0.98 PLA2G2A (0.35) PLA2G2APLA2G4APLA2G10HCRTR1PIM1
SCHEMBL25458775 0.98 PIM3 (0.35) PLA2G2APLA2G4APLA2G10HCRTR1PIM1
SCHEMBL23913427 0.96 PLA2G2A (0.36) PLA2G2APLA2G4APLA2G10HCRTR1PIM1
SCHEMBL22760327 0.96 PRKDC (0.35) PLA2G2APLA2G4APLA2G10HCRTR1PIM1
SCHEMBL24264149 0.96 PRKDC (0.35) PLA2G2APLA2G4APLA2G10HCRTR1PIM1
SCHEMBL24264153 0.96 PRKDC (0.35) PLA2G2APLA2G4APLA2G10HCRTR1PIM1
SCHEMBL25645671 0.96 HCRTR1 (0.36) PLA2G2APLA2G4APLA2G10HCRTR1PIM1
SCHEMBL22240539 0.95 PLA2G2A (0.35) PLA2G2APLA2G4APLA2G10HCRTR1PIM1
SCHEMBL25645642 0.95 PRKDC (0.36) PLA2G2APLA2G4APLA2G10HCRTR1MMP12
SCHEMBL24216811 0.95 PRKDC (0.36) PLA2G2APLA2G4APLA2G10HCRTR1PIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, TRPC1 PLA2G2A 3896/4885PLA2G4A 4007/4885PLA2G10 4496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.